Metraipolis › archive › dc_b50ca35110e0

Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma — Europe PMC PMID:41375019

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41375019
DOI
10.3390/cancers17233818
License (as archived)
solo-consultazione
Archived
2026-11-08T04:44:02.888Z
SHA-256 of the archived text
67247e2e1d1967359ba6143ed4e77db59911dac9f579f1b769d3fbd859b4d456
Stable URL of this page
https://metraipolis.com/documento/dc_b50ca35110e0

How to cite

Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma — Europe PMC PMID:41375019 — Europe PMC (en), https://europepmc.org/article/MED/41375019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b50ca35110e0 (Metraipolis archive dc_b50ca35110e0, sha256 67247e2e1d1967359ba6143ed4e77db59911dac9f579f1b769d3fbd859b4d456)
BibTeX
@misc{dcb50ca35110e0,
  title = {Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma — Europe PMC PMID:41375019},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375019},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b50ca35110e0; sha256 67247e2e1d1967359ba6143ed4e77db59911dac9f579f1b769d3fbd859b4d456},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375019. Agents can read the archived copy with the MCP tool read_document.